Keryx Biopharmaceuticals, Inc. Sued By Block & Leviton For Violations Of The Federal Securities Laws

BOSTON, Aug. 26, 2016 /PRNewswire/ -- Block & Leviton LLP (blockesq.com) announces that it has filed a class action lawsuit against Keryx Biopharmaceuticals, Inc. ("Keryx" or the "Company") (NASDAQ:  KERX) and certain of its officers for violations of the federal securities...